Type 2 Diabetes Mellitus

• CLINICAL_TRIALS trial_result · 2017-02-23
  Clinical Trial Update: A Study of Omarigliptin (MK-3102) in Participants With Type 2 Diabetes Mellitus With Chronic Kidney Disease or Kidney Failure on Dialysis (MK-3102-019) [Phase 3]

  Phase 3 study of Omarigliptin (MK-3102) in people with type 2 diabetes and chronic kidney disease or dialysis; trial completed and results p…

• CLINICAL_TRIALS trial_result · 2017-02-23
  Clinical Trial Update: To Assess the Effects of Valsartan on Albuminuria/Proteinuria in Hypertensive Patients With Type 2 Diabetes Mellitus [Phase 4]

  A Phase 4 trial assessing valsartan's impact on albuminuria and proteinuria in hypertensive patients with type 2 diabetes has completed.

• CLINICAL_TRIALS trial_result · 2017-02-23
  Clinical Trial Update: Clinical Trial for PB-119 in Subjects With Type 2 Diabetes Mellitus [Phase 1]

  Phase 1 clinical trial of PB-119 in Type 2 Diabetes Mellitus has completed.

• FDA approval · 2017-02-23
  FDA Approved: METFORMIN HYDROCHLORIDE — Original Application (Marlex Pharmaceuticals, Inc.)

  FDA approved Metformin Hydrochloride as a generic drug under an Original Application (ANDA 202306) from Marlex Pharmaceuticals, Inc. This ex…

• CLINICAL_TRIALS trial_result · 2017-02-23
  Clinical Trial Update: Effect of Vildagliptin on Fat and Muscle Metabolism in Patients With Type 2 Diabetes [Phase 3]

  A Phase 3 study evaluating the effect of vildagliptin on fat and muscle metabolism in patients with type 2 diabetes; the trial status is com…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS research · 2017-02-23
  Clinical Trial Update: A Comparison of Exenatide and Insulin Glargine [Phase 4]

  A Phase 4 clinical trial comparing Exenatide and Insulin Glargine in type 2 diabetes has completed.

• CLINICAL_TRIALS trial_result · 2017-02-23
  Clinical Trial Update: A Study to Assess the Acute Effects of Vildagliptin on Gastric Emptying in Patients With Type 2 Diabetes. [Phase 3]

  A completed Phase 3 study evaluating the acute effects of vildagliptin on gastric emptying in patients with Type 2 diabetes.

• CLINICAL_TRIALS trial_result · 2017-02-23
  Clinical Trial Update: Extension to a Study on the Efficacy and Safety of Vildagliptin in Combination With Pioglitazone in Patients With Type 2 Diabetes [Phase 3]

  Extension of a Phase 3 trial evaluating the efficacy and safety of combining vildagliptin with pioglitazone in patients with Type 2 Diabetes…

• CLINICAL_TRIALS trial_result · 2017-02-23
  Clinical Trial Update: Phase 4 Study in the Elderly Patients With T2DM [Phase 4]

  A Phase 4 clinical trial in elderly patients with Type 2 Diabetes Mellitus sponsored by Novartis has completed.

• CLINICAL_TRIALS trial_result · 2017-02-23
  Clinical Trial Update: Forxiga Tablets Specific Clinical Experience Investigation for Elderly

  This clinical trial update reports the completion of a study evaluating Forxiga (dapagliflozin) tablets in elderly patients with Type 2 Diab…

• CLINICAL_TRIALS trial_result · 2017-02-23
  Clinical Trial Update: A Study of Aleglitazar in Combination With Metformin in Patients With Type 2 Diabetes Mellitus Who Are Inadequately Controlled With Metformin Alone [Phase 3]

  A Phase 3 study evaluated Aleglitazar in combination with Metformin in adults with Type 2 diabetes mellitus inadequately controlled on Metfo…

• CLINICAL_TRIALS trial_result · 2017-02-23
  Clinical Trial Update: The Metabolic Effects of Short-term Walnut Consumption in Subjects With the Metabolic Syndrome [NA]

  A completed clinical trial investigated the metabolic effects of short-term walnut consumption in individuals with metabolic syndrome and ty…

• CLINICAL_TRIALS trial_result · 2017-02-23
  Clinical Trial Update: Regulating Efficacy and Wellness in Diabetes [NA]

  The clinical trial sponsored by the University of Illinois at Urbana-Champaign investigating type 2 diabetes mellitus and metabolic syndrome…

• CLINICAL_TRIALS research · 2017-02-23
  Clinical Trial Update: The Individualized Behavioral Intervention of Smartphone App in the Treatment of Type 2 Diabetes Mellitus [NA]

  An update on a clinical trial evaluating an individualized behavioral intervention delivered via a smartphone app for Type 2 diabetes mellit…

• CLINICAL_TRIALS research · 2017-02-23
  Clinical Trial Update: The Application of the E-health Education on Shared Care Program for Patients With Type 2 Diabetes [NA]

  This trial update describes an ongoing study of an e-health education program designed to support shared care for patients with Type 2 Diabe…

• CLINICAL_TRIALS trial_result · 2017-02-20
  Clinical Trial Update: Efficacy and Safety of Repaglinide Combined With Insulin NPH in Subjects With Type 2 Diabetes [Phase 3]

  Phase 3 study assessing the efficacy and safety of combining repaglinide with insulin NPH in Type 2 diabetes has completed.

• CLINICAL_TRIALS trial_result · 2017-02-20
  Clinical Trial Update: Efficacy and Safety of Repaglinide and Metformin Combined in Type 2 Diabetes [Phase 4]

  Phase 4 clinical trial evaluating the efficacy and safety of combining repaglinide with metformin in adults with Type 2 diabetes mellitus.

• CLINICAL_TRIALS trial_result · 2017-02-20
  Clinical Trial Update: Comparison of Repaglinide and Metformin Administered Alone or in Combination in Type 2 Diabetes [Phase 4]

  A Phase 4 trial comparing repaglinide and metformin administered alone or in combination in Type 2 diabetes has completed. The study was spo…

• CLINICAL_TRIALS trial_result · 2017-02-20
  Clinical Trial Update: Efficacy and Safety of Repaglinide, Glurenorm® and Glucobay® in Chinese Subjects With Type 2 Diabetes [Phase 4]

  Phase 4 trial assessing the efficacy and safety of Repaglinide, Glurenorm, and Glucobay in Chinese subjects with Type 2 diabetes.

• CLINICAL_TRIALS trial_result · 2017-02-20
  Clinical Trial Update: Comparison of Efficacy and Safety of Repaglinide Combined With Insulin NPH Versus Biphasic Human Insulin 30 Alone in Inadequately Controlled Subjects With Type 2 Diabetes [Phase 4]

  Phase 4 clinical trial comparing repaglinide plus insulin NPH versus biphasic human insulin 30 in adults with inadequately controlled type 2…

• CLINICAL_TRIALS trial_result · 2017-02-20
  Clinical Trial Update: Efficacy and Safety of Repaglinide Combined With Insulin in Type 2 Diabetes [Phase 4]

  This phase 4 clinical trial update assesses the efficacy and safety of combining repaglinide with insulin in patients with type 2 diabetes.

• CLINICAL_TRIALS trial_result · 2017-02-20
  Clinical Trial Update: Efficacy of Repaglinide in Subjects With Type 2 Diabetes [Phase 4]

  This Phase 4 clinical trial update reports the efficacy findings of repaglinide in subjects with type 2 diabetes, and indicates the study is…

• CLINICAL_TRIALS trial_result · 2017-02-20
  Clinical Trial Update: Comparison of Metformin, Repaglinide or the Combination of Both in Subjects With Type 2 Diabetes [Phase 4]

  A Phase 4 trial comparing metformin, repaglinide, and the combination of both in adults with Type 2 diabetes has completed.

• CLINICAL_TRIALS trial_result · 2017-02-20
  Clinical Trial Update: Observational Study of NovoNorm® in Subjects With Diabetes

  An update on a completed observational study evaluating NovoNorm (repaglinide) in subjects with diabetes, including type 2 diabetes.

• CLINICAL_TRIALS research · 2017-02-20
  Clinical Trial Update: Laser Treatment for Onychomycosis in Diabetes [NA]

  Clinical trial update on laser treatment for onychomycosis in people with Type 2 diabetes mellitus.